AnalystsTessa Romero
Tessa Romero's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 17%
#831 out of 5067 analysts
Average Return
+18.85%
Win Rate
39%20 out of 51
Risk vs Reward
Poor
Good

Tessa Romero's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Scholar Rock Holding CorpSRRK
+397.74%$7.07$35.19
2024-10-03 -
2025-10-02
Strong Buy
Dyne Therapeutics IncDYN
+307.09%$10.58$43.07
2023-08-09 -
2024-08-08
Strong Buy
Lexeo Therapeutics IncLXEO
+222.43%$2.72$8.77
2025-05-30 -
2025-10-16
Strong Buy
Biohaven LtdBHVN
+174.33%$14.65$40.19
2023-01-04 -
2024-01-03
Strong Buy
Edgewise Therapeutics IncEWTX
+132.39%$7.75$18.01
2023-06-30 -
2024-06-28
Strong Buy

Tessa Romero's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Acadia Pharmaceuticals IncACAD
10Strong Buy$33.00+60.04%Maintains
18 days ago
Edgewise Therapeutics IncEWTX
9Strong Buy$30.00+95.82%Maintains
2 months ago
Dyne Therapeutics IncDYN
6Hold$9.00-45.19%Maintains
3 months ago
Biohaven LtdBHVN
7Strong Buy$55.00+233.74%Maintains
4 months ago
Cytokinetics IncCYTK
5Strong Buy$53.00-10.11%Maintains
4 months ago
Lexeo Therapeutics IncLXEO
2Strong Buy$10.00+14.03%Maintains
5 months ago
Upstream Bio IncUPB
1Strong Buy$38.00+70.56%Initiates Coverage On
a year ago
Neumora Therapeutics IncNMRA
4Hold$15.00+742.70%Downgrades
a year ago
Scholar Rock Holding CorpSRRK
4Strong Buy$31.00N/AMaintains
a year ago
Eyepoint Pharmaceuticals IncEYPT
3Strong Buy$29.00N/AMaintains
a year ago
Agios Pharmaceuticals IncAGIO
6Hold$46.00N/AReinstates
a year ago
Y Mabs Therapeutics IncYMAB
5Strong Sell$7.00N/AMaintains
2 years ago
Xenon Pharmaceuticals IncXENE
2Strong Buy$55.00N/AMaintains
2 years ago
Seres Therapeutics IncMCRB
1Hold$140.00N/AInitiates Coverage On
2 years ago
Global Blood Therapeutics IncGBT
2Hold$36.00N/AMaintains
3 years ago
Orchard Therapeutics PLCORTX
1Strong Buy$150.00N/AAssumes
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.